Baumgarten G, Grohe C, Hoeft A, Knuefermann P
Klinik für Anästhesiologie und spezilae Intensivmedizin, Rheinischen Friedrich-Wilhelms-Universität, Bonn.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2004 Apr;39(4):197-203. doi: 10.1055/s-2004-814364.
Chronic heart failure is a major cause for mortality and morbidity in western civilizations. Previous hypothesises regarding the pathogenesis of chronic heart failure did not sufficiently explain the aetiology and the progression of the disease. However, it has been shown that a group of peptides called cytokines are expressed during chronic heart failure and that cytokines might play an important role for the pathogenesis. The expression of cytokines can be modulated from specific ACE-inhibitors as well as from different beta-blockers and angiotensin type 1 antagonists. Numerous investigations have shown that cytokines depress left ventricular function and can be responsible for different characteristics of chronic heart failure. The present article resumes experimental and clinical investigations and recent pharmacologic attempts for the treatment of chronic heart failure. The previous results demonstrate the importance to further investigate anti-inflammatory approaches to treat chronic heart failure.
慢性心力衰竭是西方文明中导致死亡和发病的主要原因。先前关于慢性心力衰竭发病机制的假说未能充分解释该疾病的病因和进展。然而,已经表明,一组称为细胞因子的肽在慢性心力衰竭期间表达,并且细胞因子可能在发病机制中起重要作用。细胞因子的表达可由特定的血管紧张素转换酶抑制剂以及不同的β受体阻滞剂和1型血管紧张素拮抗剂调节。大量研究表明,细胞因子会降低左心室功能,并可能导致慢性心力衰竭的不同特征。本文总结了治疗慢性心力衰竭的实验和临床研究以及近期的药物治疗尝试。先前的结果表明,进一步研究抗炎方法治疗慢性心力衰竭具有重要意义。